Articles Tagged With:
-
CDC Backs Down on Testing Controversy
After widespread criticism from the medical community, the Centers for Disease Control and Prevention dropped a controversial recommendation that de-emphasized the importance of testing asymptomatic contacts of COVID-19 cases.
-
Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
Presenting with persistent inattentiveness and/or hyperactivity and impulsivity severe enough to interfere with functioning, and occurring in more than one setting, attention deficit hyperactivity disorder is one of the most common neurodevelopmental disorders of childhood, with evidence of impairment often continuing into adult years.
-
COVID-19 Prevention May Equal Flu Prevention
Masking, physical distancing, and other measures implemented to slow the pandemic appear to be dramatically reducing influenza outbreaks.
-
Vomiting and Diarrhea in Immunocompromised Patients
Patients who are immunosuppressed may exhibit subtle or atypical presentations of gastrointestinal infection, as well as complications of their underlying disease processes or treatments. Emergency physicians should maintain a high level of suspicion for life-threatening pathology and evaluate these patients using broad differentials.
-
High Blood Pressure Control, Awareness on the Decline Among U.S. Adults
Health groups lament a trend that could undo years of work.
-
Infectious Disease Alert Updates
IL-6 Inhibition and Liver Failure; Can Chopsticks Make You Sick?
-
Vitamin C, Thiamine, and Steroids for Septic Shock — Still Unproven
Combination treatment with ascorbic acid (vitamin C), thiamine (vitamin B1), and corticosteroids does not improve clinical outcomes in adults with septic shock.
-
Biofilm, Tap Water, and a Nosocomial Mycobacterium abscessus Outbreak — Bring on the Sterile Water
Stopping a nosocomial Mycobacterium abscessus outbreak by eschewing tap water.
-
Possible Aerosol Spread of SARS-CoV-2 in an Apartment Building
Although not definitive, evidence is consistent with aerosol spread of SARS-CoV-2 in an apartment building as a result of transport through the drainage system to apartments directly above.
-
Four Months of Rifampin Is Just as Effective, Safer, and Less Expensive than Nine Months of Isoniazid for Latent Tuberculosis
A health system cost comparison found that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.